TAM
BMY.RT

Tocqueville Asset Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Tocqueville Asset Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-21,043
Closed -$15K – 751
2020
Q4 		$15K Sell
21,043
-700
-3% -$1.49K ﹤0.01% 701
2020
Q3 		$49K Sell
21,743
-1,800
-8% -$5.14K ﹤0.01% 642
2020
Q2 		$84K Sell
23,543
-3,600
-13% -$13K ﹤0.01% 644
2020
Q1 		$103K Sell
27,143
-8,070
-23% -$26.6K ﹤0.01% 618
2019
Q4 		$106K Buy
+35,213
New +$91.6K ﹤0.01% 717

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Tocqueville Asset Management's BMY.RT Position: Q1 2021 in Review

Tocqueville Asset Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 21,043 shares — an estimated $15K sold.

Tocqueville Asset Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $106K in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Tocqueville Asset Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Tocqueville Asset Management sold 21,043 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $15K.
  • Tocqueville Asset Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Tocqueville Asset Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $106K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Tocqueville Asset Management's 13F filing for Q1 2021, filed 17 May 2021.